Occudo Quantitative Strategies’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40,486
Closed -$429K 772
2024
Q1
$429K Sell
40,486
-3,165
-7% -$31.7K 0.07% 349
2023
Q4
$524K Buy
+43,651
New +$358K 0.07% 384
2022
Q4
Sell
-101,471
Closed -$1.73M 1008
2022
Q3
$1.73M Buy
+101,471
New +$2.18M 0.13% 223
2021
Q1
Sell
-7,922
Closed -$574K 769
2020
Q4
$574K Buy
+7,922
New +$459K 0.18% 195

Other funds holding CDNA

Occudo Quantitative Strategies's CDNA Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of CareDx (CDNA) in Q2 2024, closing a stake of 40,486 shares — an estimated $429K sold.

Occudo Quantitative Strategies first reported a position in CDNA in Q4 2020 and held it in 4 quarters. The position peaked at $1.73M in Q3 2022. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining CareDx position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 40,486 CareDx shares in Q2 2024, an estimated $429K.
  • Occudo Quantitative Strategies first reported a position in CareDx in Q4 2020 and held it in 4 quarters.
  • Occudo Quantitative Strategies's CareDx position peaked at $1.73M in Q3 2022.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.